Clone of MyMatrixx Image Partnering with you to help injured workers on their path to recovery.Powerful, affordable pharmacy solutions for your workers' compensation program.Working together,working for better. New Branding, Same MyMatrixx PromiseLEARN MORE News July 9, 2024 Connect with MyMatrixx at #WCI2024 April 23, 2024 MyMatrixx Releases 2024 Pharmacy Guidebook Featuring the Top Workers' Compensation Medications March 22, 2024 Unveiling MyMatrixx by Evernorth's New Brand Look February 6, 2024 myMatrixx Releases Final Demystifying Drug Pricing Series White Papers on Specialty Drugs, Physician Dispensing and Compounding September 19, 2023 DISCOVER OUR 2023 DEMYSTIFYING DRUG PRICING SERIES (PART TWO): Examining the Impact of Opioids on Drug Spend Read more Blogs July 19, 2024 Let’s Automate Medication Authorization July 9, 2024 WorkCompWire Leaders Speak: Weight Loss Drugs and Workers’ Comp June 10, 2024 Helping Heroes Fight Cancer March 22, 2024 For Long-Term Workers’ Compensation Complex Claims, Healthy Can Still Happen February 20, 2024 Facts to Know: FDA-Approved Narcan Nasal Spray Over the Counter Read more PharmaWatch July 22, 2024 Mislabeling Leads to Voluntary Clonazepam Recall July 22, 2024 ODG Formulary Updates for “Y” and “N” Drugs July 11, 2024 Q2 2024 New Drug Report (April-June) June 24, 2024 Opioid Nucynta Gets Six-Month Extension of Exclusivity – Generic Options to Hold June 24, 2024 Georgia BWC Fee Schedule Amendment for Topicals 2023 Demystifying Drug Pricing in Workers' Comp White Paper Series Part Two: Examining the Impact of Opioids on Drug Spend VIEW REPORT INFOGRAPHIC: Addressing a Growing Pain Point in Workers' Compensation Learn how our One Drug Review is your remedy and cost saver for topicals DOWNLOAD NOW
April 23, 2024 MyMatrixx Releases 2024 Pharmacy Guidebook Featuring the Top Workers' Compensation Medications
February 6, 2024 myMatrixx Releases Final Demystifying Drug Pricing Series White Papers on Specialty Drugs, Physician Dispensing and Compounding
September 19, 2023 DISCOVER OUR 2023 DEMYSTIFYING DRUG PRICING SERIES (PART TWO): Examining the Impact of Opioids on Drug Spend